Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
March 01, 2021 18:26 ET
|
Achilles Therapeutics
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States London, UK 1 March 2021 – Achilles Therapeutics plc (“Achilles” or the...
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer
November 11, 2020 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer
November 11, 2020 02:00 ET
|
Achilles Therapeutics
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer
June 23, 2020 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer
June 23, 2020 02:00 ET
|
Achilles Therapeutics
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...
Achilles Therapeutics appoints Carsten Boess to the Board of Directors
April 07, 2020 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...
Achilles Therapeutics appoints Carsten Boess to the Board of Directors
April 07, 2020 02:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer
March 17, 2020 08:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer
March 17, 2020 03:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...
Achilles Therapeutics Appoints Beverley Carr as Chief Business Officer
October 21, 2019 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics Appoints Beverley Carr as Chief Business OfficerBrings 20+ years of business development experience Formerly VP, Business Development for the Immuno-inflammation Therapy Area at...